Michael Bakes

Hispanic Broadcasting Corp. used to broadcast spanish language radio programs. The company was an operator of spanish language radio broadcasting stations. It operated radio stations in Los Angeles, New York, Miami, San Francisco, San Jose, Chicago, Houston, San Antonio, Dallas, Fort Worth, McAllen, Brownsville, Harlingen, San Diego, Phoenix and El Paso. Hispanic Broadcasting was headquartered in Dallas, TX.

Univision Communications, Inc. provides television and radio network services. It operates a Spanish-language broadcast television network. The firm produces and delivers content across various media platforms to inform, entertain, and empower Hispanic America. The company was founded in 1961 and is headquartered in New York, NY.

Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC.

Part of TelevisaUnivision, Inc., Univision Radio, Inc. provides radio broadcasting services. The company is based in Dallas, TX.

Founded in 1998, Covera Ventures, formerly Hunt Ventures, is a venture capital firm headquartered in Dallas, Texas. The firm spun out from Hunt Consolidated, Inc. in 2009.

Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD.

PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas.

Carnegie Institution of Washington is engaged in providing technical and scientific research services. The company was founded by Andrew Carnegie in 1895 and is headquartered in Washington, DC.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Tichenor Ventures LLC (Tichenor Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Dallas, Texas.

Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA.

Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022.